| |
| |
| |
| General Information About Alzheimer's Disease | |
| |
| |
| What Is Alzheimer's Disease? | |
| |
| |
| How Does Alzheimer's Disease Affect Patients� Lives? | |
| |
| |
| Stages of Alzheimer's Disease | |
| |
| |
| How Common Is Alzheimer's Disease? | |
| |
| |
| What Are the Risk Factors and Potential Protective Factors in Alzheimer's Disease? | |
| |
| |
| Risk Factors | |
| |
| |
| Protective Factors | |
| |
| |
| Chapter Summary | |
| |
| |
| |
| Diagnosing and Assessing Alzheimer's Disease | |
| |
| |
| What Are the Typical Presenting Features in Patients With Alzheimer's Disease? | |
| |
| |
| Cognition | |
| |
| |
| Activities of Daily Living | |
| |
| |
| Behavior | |
| |
| |
| What Are the Criteria for Diagnosing Alzheimer's Disease? | |
| |
| |
| What Tools Are Available for Clinical Assessment of Alzheimer's Disease? | |
| |
| |
| Clinical Interview (Medical and Psychiatric History) | |
| |
| |
| Laboratory Evaluations | |
| |
| |
| Radiological Findings | |
| |
| |
| Genetic Testing | |
| |
| |
| Neuropsychological Testing | |
| |
| |
| Diagnostic Workup Summary | |
| |
| |
| What Differentiates Alzheimer's Disease From Normal Aging and From Other Disorders? | |
| |
| |
| Normal Aging | |
| |
| |
| Subjective Cognitive Impairment | |
| |
| |
| Age-Associated Memory Impairment | |
| |
| |
| Mild Cognitive Impairment | |
| |
| |
| Vascular Dementia | |
| |
| |
| Lewy Body Dementia (LBD) | |
| |
| |
| Parkinson Disease Dementia (PDD) | |
| |
| |
| Mixed Dementia | |
| |
| |
| Frontotemporal Dementia | |
| |
| |
| Geriatric Depression | |
| |
| |
| Chapter Summary | |
| |
| |
| |
| Pharmacotherapy in Alzheimer's Disease | |
| |
| |
| What are the Neuroanatomical and Neurochemical Hallmarks of Alzheimer's Disease? | |
| |
| |
| Biochemical Factors Related to Alzheimer's Disease | |
| |
| |
| Specific Brain Areas Involved in Alzheimer's Disease | |
| |
| |
| What Medications Are Available for Stabilization or Improvement of Symptoms in Patients With Alzheimer's Disease? | |
| |
| |
| Cholinesterase Inhibitors (ChEI) | |
| |
| |
| NMDA Receptor Antagonist: Memantine (Namenda) | |
| |
| |
| Treatment Recommendations for Patients With Alzheimer's Disease | |
| |
| |
| Efficacy of Treatment | |
| |
| |
| What Medications Are Used to Treat BPSD in Patients With Alzheimer's Disease, and What Are Their Efficacies? | |
| |
| |
| Atypical Antipsychotics | |
| |
| |
| Typical or Conventional Antipsychotics | |
| |
| |
| Antidepressant Medications | |
| |
| |
| Benzodiazepines | |
| |
| |
| Anticonvulsants | |
| |
| |
| Cholinesterase Inhibitors | |
| |
| |
| Memantine | |
| |
| |
| What Alternative Treatments Can Be Used to Treat Patients With Alzheimer's Disease? | |
| |
| |
| Estrogen | |
| |
| |
| Omega-3 Fatty Acids | |
| |
| |
| Vitamin C and Vitamin E | |
| |
| |
| Mediterranean Diet | |
| |
| |
| What Are the Emerging or Disease-Modifying Treatments for Patients With Alzheimer's Disease? | |
| |
| |
| Anti-Inflammatory Drugs | |
| |
| |
| Statins | |
| |
| |
| Amyloid-Modifying Agents | |
| |
| |
| Immune Therapies | |
| |
| |
| Neurogenesis Agents | |
| |
| |
| Methylene Blue | |
| |
| |
| How Does Comorbidity Affect Pharmacotherapy Choices for Alzheimer's Disease? | |
| |
| |
| Comorbid Conditions | |
| |
| |
| Cost of Caring for Alzheimer's Disease Patients With Comorbid Conditions | |
| |
| |
| How Can Alzheimer's Disease Be Prevented Through Lifestyle Modifications? | |
| |
| |
| Chapter Summary | |
| |
| |
| |
| Psychosocial Treatments for Alzheimer's Disease | |
| |
| |
| What Psychosocial Interventions Are Used to Treat BPSD in Patients With Alzheimer's Disease, and How Effective Are They? | |
| |
| |
| Depression | |
| |
| |
| Anxiety | |
| |
| |
| Wandering | |
| |
| |
| Apathy | |
| |
| |
| Agitation | |
| |
| |
| Psychosis | |
| |
| |
| Sleep Abnormalities | |
| |
| |
| What Other Therapeutic Interventions Can Be Tried in Patients With Alzheimer's Disease? | |
| |
| |
| Reminiscence Therapy | |
| |
| |
| Validation Therapy | |
| |
| |
| Reality Orientation | |
| |
| |
| Chapter Summary | |
| |
| |
| |
| Ethical, Legal, and Caregiver Issues in Alzheimer's Disease | |
| |
| |
| What Are the Important End-of-Life Issues in Alzheimer's Disease? | |
| |
| |
| When to Stop Treatments | |
| |
| |
| Feeding Issues in Patients With Alzheimer's Disease | |
| |
| |
| Hospice Care for Patients With Alzheimer's Disease | |
| |
| |
| What Are the Important Legal Issues Confronting Families of Patients With Alzheimer's Disease? | |
| |
| |
| Advance Directives | |
| |
| |
| Guardianship | |
| |
| |
| What Are the Important Issues for Caregivers of Patients With Alzheimer's Disease? | |
| |
| |
| Stress | |
| |
| |
| Role of Caregiver Education in Delaying Institutionalization | |
| |
| |
| Resources for Caregivers of Patients With Alzheimer's Disease | |
| |
| |
| What Are the Various Care Options for Patients With Alzheimer's Disease?80 | |
| |
| |
| Adult Daycare Centers | |
| |
| |
| Assisted Living | |
| |
| |
| Nursing Homes | |
| |
| |
| Special Care Units | |
| |
| |
| Chapter Summary | |
| |
| |
| Appendix: Resources for Caregivers and Physicians | |
| |
| |
| Resources for Caregivers | |
| |
| |
| Internet Resources | |
| |
| |
| Books and Articles | |
| |
| |
| Internet Resources for Physicians | |
| |
| |
| Glossary | |
| |
| |
| References | |
| |
| |
| Index | |